CD38 ANTIBODY DARATUMUMAB - NOVEL TREATMENT FOR ANTIBODY-MEDIATED GRAFT REJECTION SHORTLY AFTER ORTHOTOPIC HEART TRANSPLANTATION IN HIGHLY SENSITIZED RECIPIENTS
TRANSPLANT INTERNATIONAL(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
TRANSPLANT INTERNATIONAL(2021)